Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacokinetics in the elderly.

E J Triggs, R L Nation, A Long

    European Journal of Clinical Pharmacology
    |January 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Genetic risk-targeted islet autoantibody screening for presymptomatic type 1 diabetes in adults.

    The lancet. Diabetes & endocrinology·2025
    Same author

    Multiomics informed mathematical model for meropenem and tobramycin against hypermutable Pseudomonas aeruginosa.

    International journal of antimicrobial agents·2025
    Same author

    Multi-criteria analysis of strategies towards sustainable recycling of phosphorus from sewage sludge in Austria.

    Journal of environmental management·2024
    Same author

    Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM).

    Journal of neuro-oncology·2024
    Same author

    Correction to: A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma.

    Journal of neuro-oncology·2024
    Same author

    A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma.

    Journal of neuro-oncology·2023

    Drug absorption was similar in young and elderly individuals. However, geriatric subjects showed longer half-lives for sulphamethizole and paracetamol, indicating slower drug elimination in older adults.

    Area of Science:

    • Pharmacokinetics and drug metabolism
    • Geriatric pharmacology
    • Drug safety in aging populations

    Background:

    • Understanding age-related changes in drug pharmacokinetics is crucial for optimizing therapeutic outcomes and minimizing adverse events.
    • Previous research has yielded varied results regarding the impact of aging on drug absorption, distribution, metabolism, and excretion.
    • Specific data on the comparative pharmacokinetics of sulphamethizole, paracetamol, and phenylbutazone in young versus geriatric subjects is limited.

    Purpose of the Study:

    • To investigate and compare the pharmacokinetic profiles of sulphamethizole, paracetamol, and phenylbutazone in young and geriatric subjects.
    • To determine the influence of increasing age on drug absorption, elimination half-lives, and volumes of distribution.
    • To explore potential correlations between drug elimination rates and subject-specific parameters in different age groups.

    Related Experiment Videos

    Main Methods:

    • Comparative pharmacokinetic study design involving young and geriatric human subjects.
    • Administration of sulphamethizole, paracetamol, and phenylbutazone.
    • Analysis of drug absorption rates, elimination half-lives, and apparent volumes of distribution.
    • Statistical analysis to assess age-dependent differences and identify correlations.

    Main Results:

    • Drug absorption rates and extents were not significantly affected by subject age.
    • Mean half-lives for sulphamethizole and paracetamol were significantly prolonged in geriatric subjects compared to young subjects.
    • Elimination of phenylbutazone and apparent volumes of distribution for all three drugs showed no significant age-dependent influence.
    • Correlations were observed between drug elimination rate constants and various subject parameters.

    Conclusions:

    • Age does not significantly alter the absorption or distribution of sulphamethizole, paracetamol, and phenylbutazone.
    • Geriatric individuals exhibit significantly slower elimination of sulphamethizole and paracetamol, necessitating potential dosage adjustments.
    • Phenylbutazone pharmacokinetics appear relatively stable across different age groups.
    • Further research into subject-specific factors influencing drug elimination in the elderly is warranted.